AZITHROMYCIN: MODERN PLACE OF THE DRUG IN THERAPY OF LOWER RESPIRATORY TRACTS INFECTIONS
One of the important problems in pulmonology – lower respiratory tract infections that occupy a significant place in the structure of the pulmonary pathology. The major nosological entities at which this infection is the leading or the major ethiologic factor of the lower respiratory tract lesion is...
Main Authors: | S. I. Sazhnova, N. A. Karoli, A. P. Rebrov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2038 |
Similar Items
-
In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
by: Mendes Caio M. F., et al.
Published: (2001-01-01) -
In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
by: Caio M. F. Mendes, et al. -
Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections
by: Surinder Kumar
Published: (2018-01-01) -
Approaches to the treatment of diseases of the lower respiratory tract: choice of antibacterial preparati on taking into account international recommendations
by: S.O. Kramarov, et al.
Published: (2018-11-01) -
Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial
by: Fernando G. Rubio, et al.